Chemical
Aarti Drugs posts 38% higher income in Q4FY22
Company's net profit grew by 7% and stood at Rs.55.34 crores in Q4 as against Rs.51.65 crores last year
- By ICN Bureau
| May 10, 2022
Aarti Drugs Ltd has posted a 38% rise in income to reach Rs. 697.23 crores during the period ended March 31, 2022 as compared to Rs.502.72 crores during the period ended March 31, 2021.
Company's net profit grew by 7% and stood at Rs.55.34 crores in Q4 as against Rs.51.65 crores last year.
Company's EPS also rose 7.76% and reached Rs.5.97 in Q4 as compared to Rs.5.54 for the period ended March 31, 2021.
For the full year, the company's total income grew by 15.78% and stood at Rs.2499.96 crores in 2022 as compared to Rs.2159.30 crores in 2021.
However the company's net profit dropped by -26% and reached Rs.205.04 crores in 2022 as against Rs.280.41 crores in 2021.
EPS for the full year also dropped by -26% and reached Rs.22.12 as compared to Rs.30.09 for the Financial Year ended March 31, 2021.
Register Now to Attend E-Conference on Digital Transformation: The Catalyst for Agile and Smarter Process R&D on June 4 at 3:00 - 4:30 PM IST
Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai
